Projected long term impact of elbasvir/grazoprevir compared to sofosbuvir plus pegylated interferon/ribavirin in chronic hepatitis C virus genotype 1 and 4 patients in Italy: translation of the C-EDGE Head-2-Head study findings

2017 ◽  
Vol 66 (1) ◽  
pp. S298-S299
Author(s):  
C. Nwankwo ◽  
R. Batterson ◽  
E. Todd ◽  
Y. Jiang ◽  
H.L. Platt ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Chronic Hepatitis C Virus ◽  
Long Term Impact

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1

2010 ◽  
Vol 139 (4) ◽  
pp. 1257-1266 ◽  
Author(s):  
Stefan Zeuzem ◽  
Mark S. Sulkowski ◽  
Eric J. Lawitz ◽  
Vinod K. Rustgi ◽  
Maribel Rodriguez–Torres ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Randomized Trial ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Α ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Chronic Hepatitis C Virus

scholarly journals Chronic Hepatitis C Virus Genotype 6 Infection: Response to Pegylated Interferon and Ribavirin

2008 ◽  
Vol 198 (6) ◽  
pp. 808-812 ◽  
Author(s):  
James Fung ◽  
Ching‐Lung Lai ◽  
Ivan Hung ◽  
John Young ◽  
Charles Cheng ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Virus Genotype ◽  
Chronic Hepatitis C Virus ◽  
Infection Response

Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection

2019 ◽  
Vol 26 (10) ◽  
pp. 1229-1232
Author(s):  
Tarik Asselah ◽  
Stephen D. Shafran ◽  
Stefan Bourgeois ◽  
Ching‐Lung Lai ◽  
Philippe Mathurin ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Fixed Dose ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Deferred Treatment ◽  
Chronic Hepatitis C Virus ◽  
Dose Combination

scholarly journals Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

Hepatology ◽  
2015 ◽  
Vol 62 (1) ◽  
pp. 25-30 ◽  
Author(s):  
Saleh A. Alqahtani ◽  
Nezam Afdhal ◽  
Stefan Zeuzem ◽  
Stuart C. Gordon ◽  
Alessandra Mangia ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Phase Iii ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Chronic Hepatitis C Virus
Sign in / Sign up

Export Citation Format

Share Document